Changeflow GovPing Pharma & Drug Safety Patent Application for Propagator Cells and Pha...
Routine Notice Added Draft

Patent Application for Propagator Cells and Phage Propagation Methods

Email

Summary

The USPTO has published a new patent application (US20260085296A1) detailing propagator cells and methods for propagating phage, particularly for delivering CRISPR-Cas components via probiotic organisms. The application was filed on December 4, 2025.

What changed

This document is a publication of a new patent application filed with the USPTO, specifically application number US20260085296A1. The application, titled 'PROPAGATOR CELLS AND METHODS FOR PROPAGATING PHAGE, IN PARTICULAR FOR DELIVERING CRISPR-CAS COMPONENTS VIA PROBIOTIC ORGANISMS,' describes novel methods and cells for phage propagation and the delivery of CRISPR-Cas components using probiotic organisms. The filing date was December 4, 2025.

As this is a patent application, it represents a request for intellectual property protection rather than a regulatory mandate. Companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in gene editing technologies, phage therapy, or probiotic development, may find the disclosed technology relevant to their research and development efforts. Reviewing such applications can provide insights into emerging technologies and potential future patent landscapes.

Source document (simplified)

← USPTO Patent Applications

PROPAGATOR CELLS AND METHODS FOR PROPAGATING PHAGE, IN PARTICULAR FOR DELIVERING CRISPR-CAS COMPONENTS VIA PROBIOTIC ORGANISMS

Application US20260085296A1 Kind: A1 Mar 26, 2026

Inventors

Jasper CLUBE

Abstract

The invention provides propagator cells and methods for propagating phage and transduction particles.

CPC Classifications

C12N 7/00 A61K 35/74 C12N 2310/20 C12N 2795/00023 C12N 2795/00032 C12N 2795/00052 C12N 2800/80

Filing Date

2025-12-04

Application No.

19409492

View original document →

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260085296A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Biotechnology Research
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Biotech (C12N) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.